HomeRLFTF • OTCMKTS
add
RELIEF THERAPEUTICS Holding SA
Previous close
$3.10
Day range
$2.95 - $3.16
Year range
$1.10 - $7.66
Market cap
36.65M CHF
Avg Volume
2.20K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 1.50M | — |
Operating expense | 5.10M | — |
Net income | -20.84M | — |
Net profit margin | -1.38K | — |
Earnings per share | — | — |
EBITDA | -3.47M | — |
Effective tax rate | 12.33% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.56M | — |
Total assets | 76.39M | — |
Total liabilities | 24.16M | — |
Total equity | 52.23M | — |
Shares outstanding | 12.54M | — |
Price to book | 0.74 | — |
Return on assets | -13.49% | — |
Return on capital | -18.23% | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -20.84M | — |
Cash from operations | -3.57M | — |
Cash from investing | 4.46M | — |
Cash from financing | -62.00K | — |
Net change in cash | 882.00K | — |
Free cash flow | 2.79M | — |
About
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Founded
2013
Website
Employees
36
